Author:
Stronkhorst Arnold,Tytgat Guido N. J.,van Deventer Sander J. H.
Reference56 articles.
1. Katz KD, Hollander D, Vadheim CM, et al. Intestinal permeability in patients with Crohn’s disease and their healthy relatives. Gas- troenterology 1989;97:927–31.
2. Howden CW, Robertson C, Ducan A, Morris AJ, Russel RI. Comparison of different measurements of intestinal permeability in inflammatory bowel disease. Am J Gastroenterol 1991;86:1445–9.
3. Madara JL, Moore R, Carlson S. Alteration of intestinal tight junction structure and permeability by cytoskeletal contraction. Am Phy Soc 1987;C854–61.
4. Ouyang Q, El-Youssef M, Yen-Lieberman B, Sapatnekar W, Youngman KR, Kusugami K, et al. Expression of HLA-DR antigens in inflammatory bowel disease mucosa: Role of intestinal lamina propria mononuclear cell-derived interferon T. Dig Dis Sci 1988;33:1528–36.
5. Cuvelier C, Mielants H, Vos de M, Veys E, Roels H. Major histocompatibility complex class II antigen (HLA-DR) expression by ileal epithelial cells in patients with seronegative spondylarthropathy. Gut 1990;31:545–9.